Metabolism
Metabolism(代谢)
- PPAR(219)
- 5-alpha Reductase(11)
- 5-Lipoxygenase(11)
- Adenosine Deaminase(10)
- Aminopeptidase(15)
- C14ɑ demethylase(2)
- Carbonic Anhydrase(55)
- CETP(9)
- Cholesterol absorption(1)
- CPT1(2)
- CYP3A/CYP450(22)
- Dehydrogenase(43)
- DHFR(7)
- DGAT(10)
- Dopamine β-hydroxylase(10)
- Enolase(5)
- FAAH(38)
- Factor Xa(61)
- Ferroptosis(198)
- Folate Analogue(2)
- Glucokinase(18)
- HLE(1)
- HMG-CoA Reductase(37)
- HSP(100)
- IDO(46)
- KRAS-PDEδ(3)
- MAO(6)
- Metabolic Enzymes(6)
- Neuronal Metabolism(8)
- Oxidative Phosphorylation(26)
- P450(456)
- PDE(250)
- Phospholipase(130)
- Procollagen C Proteinase(1)
- Saccharometabolism(1)
- SCD(20)
- SGLT(29)
- TPH(4)
- Transferase(26)
- Energy Metabolism
- Inorganic Ions
- ALP(1)
- Carbohydrates(36)
- Uric Acid
- Muscle Metabolism
- MDA
- MPO
- Transaminase(3)
- Glutathione Reductase(1)
- Thioredoxin Reductase
- Catalase(15)
- monooxygenase(1)
- PKM2(1)
- Aldehyde dehydrogenase(1)
- Squalene synthase(1)
- Hydrolase(17)
- ornithine decarboxylase(1)
- Amino acid metabolism(3)
- phosphatases(103)
- Pyruvate kinase(13)
- Others(64)
- MGL(1)
- Galactosidase(2)
- 12-Lipoxygenase(1)
- Fatty Acid Synthase (FASN)(9)
- Dihydroorotate Dehydrogenase(13)
- Bile Acids & Microbiome(131)
- Bone Growth & Remodeling(55)
- Carbohydrate Metabolism(166)
- Cofactors & Vitamins(87)
- Dyslipidemias(109)
- Inborn Errors of Metabolism(100)
- Metabolic Syndrome(22)
- Necroptosis(12)
- Necrosis(19)
- Nutrient Sensing(14)
- Phosphodiesterase(34)
- Reproductive Biology(184)
- Thermogenesis(10)
- Sterol Biosynthesis(42)
- Prolyl Hydroxylation Enzymes(2)
- Biliary System(16)
- Metabolic Disease(5)
- Fat Mass and Obesity-associated Protein (FTO)(5)
- SHIP(1)
- FOXO
- Furin(1)
- Liposome(8)
- MetAP
- PGC-1α
- PI5P4K(1)
- Metabolic Diseases(2)
Metabolism 相关产品(3072)
- GC13842Ro 20-1724CAS: 29925-17-5纯度: >98.00% / >95.00%
Ro 20-1724是一种选择性cAMP特异性磷酸二酯酶(PDE4)抑制剂,IC 50 值为1.930μM。
- GC13856Dalcetrapib (JTT-705, RO4607381)CAS: 211513-37-0纯度: >99.00%
An inhibitor of cholesteryl ester transfer protein
- GC14398SiguazodanCAS: 115344-47-3纯度: >99.00%
Siguazodan (SKF 94836) 是一种有效的、选择性的、具有口服活性的磷酸二酯酶 III (PDE-III) 抑制剂,IC50 为 117 nM。
- GC14403WY-14643 (Pirinixic Acid)CAS: 50892-23-4纯度: >99.50% / >98.00%
WY-14643 (Pirinixic Acid)是一种高效、具备选择性高亲和力的过氧化物酶体增殖物激活受体α(PPARα)受体激动剂,对小鼠的 PPARα受体的EC 50 为0.63μM,对人的 PPARα受体的EC 50 为5μM。
- GC14538Pravastatin sodiumCAS: 81131-70-6纯度: >99.00% / >98.00%
Pravastatin sodium 是一种HMG-CoA可逆的竞争性抑制剂,IC 50 为5.6μM,通常用于高胆固醇血症和冠心病的研究。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC13842 | Ro 20-1724 | 29925-17-5 | >98.00% / >95.00% | |
Ro 20-1724是一种选择性cAMP特异性磷酸二酯酶(PDE4)抑制剂,IC 50 值为1.930μM。 | ||||
| GC13856 | Dalcetrapib (JTT-705, RO4607381) | 211513-37-0 | >99.00% | |
An inhibitor of cholesteryl ester transfer protein | ||||
| GC13912 | NLG919 | 1402836-58-1 | >99.50% | |
An IDO pathway inhibitor | ||||
| GC13946 | SNX-2112 | 908112-43-6 | - | |
SNX-2112是一种强效的合成型热休克蛋白(Hsp 90)抑制剂,IC 50 值为30nM。 | ||||
| GC13969 | GW9662 | 22978-25-2 | >99.50% / >98.00% | |
GW9662是一种特异性的过氧化物酶体增殖物激活受体-γ(PPAR-γ)抑制剂,其IC50为3.3 nM。 | ||||
| GC14038 | Atorvastatin Calcium | 134523-03-8 | >99.50% | |
An HMG-CoA reductase inhibitor | ||||
| GC14061 | Evacetrapib (LY2484595) | 1186486-62-3 | >99.00% | |
A CETP inhibitor | ||||
| GC14226 | Methazolamide | 554-57-4 | >98.00% | |
A carbonic anhydrase inhibitor | ||||
| GC14269 | Cobicistat (GS-9350) | 1004316-88-4 | >98.00% | |
An inhibitor of CYP3A | ||||
| GC14308 | FK866 (APO866) | 658084-64-1 | >99.50% | |
Inhibitor of nicotinamide phosphoribosyltransferase | ||||
| GC14398 | Siguazodan | 115344-47-3 | >99.00% | |
Siguazodan (SKF 94836) 是一种有效的、选择性的、具有口服活性的磷酸二酯酶 III (PDE-III) 抑制剂,IC50 为 117 nM。 | ||||
| GC14403 | WY-14643 (Pirinixic Acid) | 50892-23-4 | >99.50% / >98.00% | |
WY-14643 (Pirinixic Acid)是一种高效、具备选择性高亲和力的过氧化物酶体增殖物激活受体α(PPARα)受体激动剂,对小鼠的 PPARα受体的EC 50 为0.63μM,对人的 PPARα受体的EC 50 为5μM。 | ||||
| GC14425 | IDO inhibitor 1 | 1204669-37-3 | - | |
Indoleamine-2,3-dioxygenase inhibitor | ||||
| GC14435 | Zileuton sodium | 118569-21-4 | - | |
A reversible inhibitor of 5-lipoxygenase | ||||
| GC14538 | Pravastatin sodium | 81131-70-6 | >99.00% / >98.00% | |
Pravastatin sodium 是一种HMG-CoA可逆的竞争性抑制剂,IC 50 为5.6μM,通常用于高胆固醇血症和冠心病的研究。 | ||||
| GC14581 | JNJ-1661010 | 681136-29-8 | >98.50% | |
A selective FAAH inhibitor | ||||
| GC14636 | KW-2478 | 819812-04-9 | >98.50% | |
An Hsp90 inhibitor | ||||
| GC14673 | Safinamide Mesylate | 202825-46-5 | >98.00% | |
An inhibitor of MAO-B | ||||
| GC14751 | Malotilate | 59937-28-9 | >99.50% | |
A hepatoprotective agent | ||||
| GC14783 | Trilostane | 13647-35-3 | >99.50% | |
A 3β-hydroxysteroid dehydrogenase inhibitor | ||||
| GC14935 | Capadenoson | 544417-40-5 | >99.00% | |
A partial adenosine receptor agonist | ||||
| GC14983 | GW0742 | 317318-84-6 | >98.00% | |
A selective agonist of PPARδ | ||||
| GC15077 | SA 47 | 792236-07-8 | >99.00% | |
SA 47 是一种选择性强效的脂肪酸酰胺水解酶 (FAAH) 和氨基甲酸酯抑制剂 。 | ||||
| GC15094 | LY2183240 | 874902-19-9 | >99.00% | |
A potent, competitive inhibitor of anandamide uptake | ||||
